Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Parkinson's Disease

Free Subscription Articles published in PLoS One Retrieve available abstracts of 142 articles: HTML format

Single Articles

January 2025
1. CONNIE T, Aderinola TB, Ong JY, Ong TS, et al
   Parkinson's disease screening using a fusion of gait point cloud and silhouette features.
   PLoS One. 2025;20:e0315453.
   PubMed     Abstract available
   
   
   
2. SONG H, Ge S, Li J, Jiao C, et al
   Effects of aerobic and resistance training on walking and balance abilities in older adults with Parkinson's disease: A systematic review and meta-analysis.
   PLoS One. 2025;20:e0314539.
   PubMed     Abstract available
   
   
   
3. GRAHAM L, Vitorio R, Walker R, Godfrey A, et al
   Digital measurement of ocular microtremor in Parkinson's disease: Protocol for a pilot study to assess reliability and clinical validation.
   PLoS One. 2025;20:e0313452.
   PubMed     Abstract available
   
   
   
4. YU B, Zhang H, Zhang M
   Deep learning-based differential gut flora for prediction of Parkinson's.
   PLoS One. 2025;20:e0310005.
   PubMed     Abstract available
   
   
   
5. ZHANG L, Jiang Y, Fan W, Xue H, et al
   Unveiling the efficacy of repetitive transcranial magnetic stimulation in Parkinson's disease: A comprehensive review of systematic analyses.
   PLoS One. 2025;20:e0313420.
   PubMed     Abstract available
   
   
   
6. RUKAVINA K, Staunton J, Zinzalias P, Krbot Skoric M, et al
   Wearable devices may aid the recognition of fluctuation-related pain in Parkinson's disease-An exploratory, cross-sectional analysis of two prospective observational studies.
   PLoS One. 2025;20:e0316563.
   PubMed     Abstract available
   
   
   
7. LEE J, Kang SH, Koh SB
   Postural instability and gait disturbance are associated with abnormal stereopsis in Parkinson's disease.
   PLoS One. 2025;20:e0317935.
   PubMed     Abstract available
   
   
   
8. LU H, Qi G, Wu D, Lin C, et al
   A novel feature extraction method based on dynamic handwriting for Parkinson's disease detection.
   PLoS One. 2025;20:e0318021.
   PubMed     Abstract available
   
   
   
9. KIM J, Kim R, Byun K, Kang N, et al
   Assessment of temporospatial and kinematic gait parameters using human pose estimation in patients with Parkinson's disease: A comparison between near-frontal and lateral views.
   PLoS One. 2025;20:e0317933.
   PubMed     Abstract available
   
   
   
10. DE ALMEIDA SB, Tavares Sobreira ES, de Lucena Alves CP, Lima DP, et al
    Effect of power training on physical functional performance of patients with Parkinson's disease: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2025;20:e0314058.
    PubMed     Abstract available
    
    
    
11. GERMANI E, Bhagwat N, Dugre M, Gau R, et al
    Predicting Parkinson's disease trajectory using clinical and functional MRI features: A reproduction and replication study.
    PLoS One. 2025;20:e0317566.
    PubMed     Abstract available
    
    
    
12. BECK EN, Wang MTY, Intzandt BN, Almeida QJ, et al
    Correction: Sensory focused exercise improves anxiety in Parkinson's disease: A randomized controlled trial.
    PLoS One. 2025;20:e0319768.
    PubMed     Abstract available
    
    
    
13. 
    Retraction: TOM40 Mediates Mitochondrial Dysfunction Induced by alpha-Synuclein Accumulation in Parkinson's Disease.
    PLoS One. 2025;20:e0319935.
    PubMed    
    
    
    
14. ABOELZAHAB YH, Bojmehrani A, Ahmed YE, Boon H, et al
    Psychological stress associated with prognostic uncertainties in recently diagnosed Parkinson's disease patients: A qualitative study.
    PLoS One. 2025;20:e0319576.
    PubMed     Abstract available
    
    
    
15. GOMEZ LF, Morales A, Fierrez J, Orozco-Arroyave JR, et al
    Correction: Exploring facial expressions and action unit domains for Parkinson detection.
    PLoS One. 2025;20:e0320872.
    PubMed     Abstract available
    
    
    
16. 
    Retraction: Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.
    PLoS One. 2025;20:e0321152.
    PubMed    
    
    
    
17. HUO H, Jiao S, Li D, Ma L, et al
    Efficient quantification of Parkinson's disease severity using augmented time-series data.
    PLoS One. 2025;20:e0319826.
    PubMed     Abstract available
    
    
    
18. SANTOS-GARCIA D, Gonzalez-Ortega G, Sanchez-Alonso P, Planas-Ballve A, et al
    Device-aided therapies (DATs) in Parkinson's disease (PD). The DATs-PD GETM Spanish Registry Protocol Study.
    PLoS One. 2025;20:e0316052.
    PubMed     Abstract available
    
    
    
19. ESTIVALET KM, Pettenuzzo TSA, Mazzilli NL, Ferreira LF, et al
    The use of brain-machine interface, motor imagery, and action observation in the rehabilitation of individuals with Parkinson's disease: A protocol study for a randomized clinical trial.
    PLoS One. 2025;20:e0315148.
    PubMed     Abstract available
    
    
    
20. HODGSON P, Jordan A, Sinani C, Charura D, et al
    The relationship between physical function and psychological symptoms in Parkinson's: Perceptions of People with Parkinson's and Carers.
    PLoS One. 2025;20:e0310578.
    PubMed     Abstract available
    
    
    
21. KIM J, Park S, Lee JH, Lee JY, et al
    Zinc finger protein 184 prevents alpha-synuclein preformed fibril-mediated neurodegeneration through the interleukin enhancer binding factor 3-microRNA-7 pathway.
    PLoS One. 2025;20:e0323279.
    PubMed     Abstract available
    
    
    
22. OKAI T, Sato S, Deshpande M, Matsumoto SI, et al
    AAV delivery of GBA1 suppresses alpha-synuclein accumulation in Parkinson's disease models and restores functions in Gaucher's disease models.
    PLoS One. 2025;20:e0321145.
    PubMed     Abstract available
    
    
    
23. ABAQUITA TAL, Damulewicz M, Pyza E
    The neuroprotective role of CncC in a Drosophila model of Parkinson's disease.
    PLoS One. 2025;20:e0322640.
    PubMed     Abstract available
    
    
    
24. GORENFLO MP, Gao Z, Davis PB, Kaelber D, et al
    Amphetamine use and Parkinson's disease: integration of artificial intelligence prediction, clinical corroboration, and mechanism of action analyses.
    PLoS One. 2025;20:e0323761.
    PubMed     Abstract available
    
    
    
25. LI Y, Jia W, Chen C, Chen C, et al
    Identification of biomarkers associated with inflammatory response in Parkinson's disease by bioinformatics and machine learning.
    PLoS One. 2025;20:e0320257.
    PubMed     Abstract available
    
    
    
26. ORAYJ K
    Trends in Parkinson's disease medication prescribing patterns in the UK: An interrupted time series analysis (2019-2024).
    PLoS One. 2025;20:e0324999.
    PubMed     Abstract available
    
    
    
27. MENDORF S, Heimrich KG, Muhlhammer HM, Schonenberg A, et al
    The influence of the Big Five inventory on quality of life in people with Parkinson's disease aged 50 and above: A Longitudinal Analysis from the Survey of Health, Aging and Retirement in Europe (SHARE).
    PLoS One. 2025;20:e0322089.
    PubMed     Abstract available
    
    
    
28. LANDER JJ, Moran MF, Alexanian HR
    Correlations of gait kinematics and cognitive skills in Parkinson disease.
    PLoS One. 2025;20:e0317389.
    PubMed     Abstract available
    
    
    
29. IBRAHIM MK, Mohammed SI, Al-Gawwam GAAS
    Neurologists' perspectives on management challenges and mitigation strategies for Parkinson's disease patients: A qualitative study in Iraq.
    PLoS One. 2025;20:e0326851.
    PubMed     Abstract available
    
    
    
30. YADAV R, Dey S, Kumar R, Mohanan AP, et al
    Progression and natural history of Atypical Parkinsonism (ATPARK): Protocol for a longitudinal follow-up study from an underrepresented population.
    PLoS One. 2025;20:e0325624.
    PubMed     Abstract available
    
    
    
31. BSOUL R, Simonsen AH, Frederiksen KS, Svenstrup K, et al
    Seeding amplification assay with Universal Control Fluid: Standardized detection of alpha-synucleinopathies.
    PLoS One. 2025;20:e0326568.
    PubMed     Abstract available
    
    
    
32. LIU T, Li J, Zhang J, Wei J, et al
    Cuproptosis-related genes associated with mitochondrial dysfunction in Parkinson's disease.
    PLoS One. 2025;20:e0327550.
    PubMed     Abstract available
    
    
    
33. ZHU Z, Wu E, Leng P, Sun J, et al
    Finger drawing on smartphone screens enables early Parkinson's disease detection through hybrid 1D-CNN and BiGRU deep learning architecture.
    PLoS One. 2025;20:e0327733.
    PubMed     Abstract available
    
    
    
34. CARAPELLOTTI AM, Rodger M, Doumas M
    Evaluating the short-term effects of dance on motor and non-motor outcomes in people living with Parkinson's: A crossover study.
    PLoS One. 2025;20:e0328293.
    PubMed     Abstract available
    
    
    
35. KIM A, Schweighofer N, Petzinger GM, Finley JM, et al
    Uncovering locomotor learning dynamics in people with Parkinson's disease.
    PLoS One. 2025;20:e0326692.
    PubMed     Abstract available
    
    
    
36. PAMLENYI K, Ferreira B, Regdon G Jr, Kristo K, et al
    Development and characterization of pramipexole dihydrochloride buccal films for Parkinson's disease treatment.
    PLoS One. 2025;20:e0329142.
    PubMed     Abstract available
    
    
    
37. JOINEAU K, Harroch E, Boussac M, Fabbri M, et al
    Effect of foot reflexology on chronic pain in Parkinson's disease: A randomized controlled trial.
    PLoS One. 2025;20:e0327865.
    PubMed     Abstract available
    
    
    
38. WANG H, Feng L, He L, Liu N, et al
    Bioinformatics analysis to explore biomarkers and mechanisms of action associated with endoplasmic reticulum stress and ferroptosis in Parkinson's disease.
    PLoS One. 2025;20:e0328682.
    PubMed     Abstract available
    
    
    
39. POLINSKI NK, Puolivali J, Rauhala L, Stenius TK, et al
    Expression of human A53T alpha-synuclein without endogenous rat alpha-synuclein fails to elicit Parkinson's disease-related phenotypes in a novel humanized rat model.
    PLoS One. 2025;20:e0329823.
    PubMed     Abstract available
    
    
    
40. KASEMSAP N, Tikkapanyo P, Wanjantuk P, Vorasoot N, et al
    Screening for Parkinson's disease using "computer vision".
    PLoS One. 2025;20:e0330373.
    PubMed     Abstract available
    
    
    
41. UMEMURA A, Sato K, Iwamuro H, Uchiyama S, et al
    Effects of transcranial direct current stimulation using a commercially available device on gait in Parkinson's disease with freezing of gait.
    PLoS One. 2025;20:e0330286.
    PubMed     Abstract available
    
    
    
42. LARSSON V, Hall S, Blennow K, Hansson O, et al
    Olfactory dysfunction and amyloid-positivity in Parkinson's disease-longitudinal analysis of cognitive decline and cerebrospinal fluid markers.
    PLoS One. 2025;20:e0325560.
    PubMed     Abstract available
    
    
    
43. PAPIC E, Racki V, Hero M, Zimani AN, et al
    Microbial diversity in drug-naive Parkinson's disease patients.
    PLoS One. 2025;20:e0328761.
    PubMed     Abstract available
    
    
    
44. NOROUZI-GHAZBI S, Mirbaha S, Li Z, Andrysek J, et al
    Gamification-based tele-rehabilitation for physical therapy in patients with Parkinson's disease: A scoping review.
    PLoS One. 2025;20:e0326705.
    PubMed     Abstract available
    
    
    
45. 
    Expression of Concern: The IkappaB Kinase Family Phosphorylates the Parkinson's Disease Kinase LRRK2 at Ser935 and Ser910 during Toll-Like Receptor Signaling.
    PLoS One. 2025;20:e0330958.
    PubMed    
    
    
    
46. RODRIGUEZ-MARTIN D, Catala A, Cabestany J
    Improving Parkinson's disease management through wearable technology: A cost-benefit perspective.
    PLoS One. 2025;20:e0334413.
    PubMed     Abstract available
    
    
    January 2024
47. KIM M, Kim D, Kang H, Park S, et al
    A machine learning model for prediction of sarcopenia in patients with Parkinson's Disease.
    PLoS One. 2024;19:e0296282.
    PubMed     Abstract available
    
    
    
48. BRUNI F, Mancuso V, Stramba-Badiale C, Stramba-Badiale M, et al
    Beyond traditional training: Integrating data from semi-immersive VR dual-task intervention in Parkinsonian Syndromes. A study protocol.
    PLoS One. 2024;19:e0294199.
    PubMed     Abstract available
    
    
    
49. SOKOLOWSKI A, Bhagwat N, Chatelain Y, Dugre M, et al
    Longitudinal brain structure changes in Parkinson's disease: A replication study.
    PLoS One. 2024;19:e0295069.
    PubMed     Abstract available
    
    
    
50. ESSAWY ESSAWY A, Abou-ElNaga OA, Mehanna RA, Badae NM, et al
    Comparing the effect of intravenous versus intracranial grafting of mesenchymal stem cells against parkinsonism in a rat model: Behavioral, biochemical, pathological and immunohistochemical studies.
    PLoS One. 2024;19:e0296297.
    PubMed     Abstract available
    
    
    
51. WAWRZICZNY E, Flinois B, Constant E, Brugalle E, et al
    Dealing with the diagnosis of Parkinson's disease and its implications for couple functioning in the early stage: An interpretative phenomenological analysis.
    PLoS One. 2024;19:e0294240.
    PubMed     Abstract available
    
    
    
52. MEIJER LL, Ruis C, Schielen ZA, Dijkerman HC, et al
    CT-optimal touch and chronic pain experience in Parkinson's Disease; An intervention study.
    PLoS One. 2024;19:e0298345.
    PubMed     Abstract available
    
    
    
53. TIAN J, Zuo C, Shi J, Ma D, et al
    Peripheral immune cell traits and Parkinson's disease: A Mendelian randomization study.
    PLoS One. 2024;19:e0299026.
    PubMed     Abstract available
    
    
    
54. MALAGUTI MC, Gios L, Giometto B, Longo C, et al
    Artificial intelligence of imaging and clinical neurological data for predictive, preventive and personalized (P3) medicine for Parkinson Disease: The NeuroArtP3 protocol for a multi-center research study.
    PLoS One. 2024;19:e0300127.
    PubMed     Abstract available
    
    
    
55. VARGA I, Bakstein E, Gilmore G, May J, et al
    Statistical segmentation model for accurate electrode positioning in Parkinson's deep brain stimulation based on clinical low-resolution image data and electrophysiology.
    PLoS One. 2024;19:e0298320.
    PubMed     Abstract available
    
    
    
56. SEUTHE J, Heinzel A, Hulzinga F, Ginis P, et al
    Towards a better understanding of anticipatory postural adjustments in people with Parkinson's disease.
    PLoS One. 2024;19:e0300465.
    PubMed     Abstract available
    
    
    
57. SCHRAG A, Kostev K
    Association of antihypertensives and Parkinson's disease in a primary care population matched for underlying diagnosis.
    PLoS One. 2024;19:e0299985.
    PubMed     Abstract available
    
    
    
58. CAI X, Jin Z, Zhang S, Liu J, et al
    Sjogren's syndrome and Parkinson's Disease: A bidirectional two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298778.
    PubMed     Abstract available
    
    
    
59. MCMAHON L, McGrath D, Blake C, Lennon O, et al
    Responsiveness of respiratory function in Parkinson's Disease to an integrative exercise programme: A prospective cohort study.
    PLoS One. 2024;19:e0301433.
    PubMed     Abstract available
    
    
    
60. SAADULLAH M, Tariq H, Chauhdary Z, Saleem U, et al
    Biochemical properties and biological potential of Syzygium heyneanum with antiparkinson's activity in paraquat induced rodent model.
    PLoS One. 2024;19:e0298986.
    PubMed     Abstract available
    
    
    
61. KHAN A, Ezeugwa J, Ezeugwu VE
    A systematic review of the associations between sedentary behavior, physical inactivity, and non-motor symptoms of Parkinson's disease.
    PLoS One. 2024;19:e0293382.
    PubMed     Abstract available
    
    
    
62. SONG J, Li J, Pei X, Chen J, et al
    Identification of cuproptosis-realated key genes and pathways in Parkinson's disease via bioinformatics analysis.
    PLoS One. 2024;19:e0299898.
    PubMed     Abstract available
    
    
    
63. ANJUM R, Raza C, Faheem M, Ullah A, et al
    Neuroprotective potential of Mentha piperita extract prevents motor dysfunctions in mouse model of Parkinson's disease through anti-oxidant capacities.
    PLoS One. 2024;19:e0302102.
    PubMed     Abstract available
    
    
    
64. MORACA GAG, Orcioli-Silva D, Legutke BR, Gutierrez PP, et al
    Aerobic exercise on the treadmill combined with transcranial direct current stimulation on the gait of people with Parkinson's disease: A protocol for a randomized clinical trial.
    PLoS One. 2024;19:e0300243.
    PubMed     Abstract available
    
    
    
65. VARGA I, Bakstein E, Gilmore G, May J, et al
    Correction: Statistical segmentation model for accurate electrode positioning in Parkinson's deep brain stimulation based on clinical low-resolution image data and electrophysiology.
    PLoS One. 2024;19:e0302985.
    PubMed     Abstract available
    
    
    
66. TABARI F, Berger JI, Flouty O, Copeland B, et al
    Speech, voice, and language outcomes following deep brain stimulation: A systematic review.
    PLoS One. 2024;19:e0302739.
    PubMed     Abstract available
    
    
    
67. ZHANG HW, Xie J, Peng HC, Lin YS, et al
    Use of antiviral drugs and incidence of Parkinson's disease in Taiwan.
    PLoS One. 2024;19:e0302383.
    PubMed     Abstract available
    
    
    
68. PARK MS, Park S, Kang JY, Jung IC, et al
    The efficacy and safety of MARS-PD: Meridian activation remedy system for Parkinson's disease-A single-center, assessor and statistician-blinded, parallel-group randomized, controlled trial protocol.
    PLoS One. 2024;19:e0303156.
    PubMed     Abstract available
    
    
    
69. ALTHAM C, Zhang H, Pereira E
    Machine learning for the detection and diagnosis of cognitive impairment in Parkinson's Disease: A systematic review.
    PLoS One. 2024;19:e0303644.
    PubMed     Abstract available
    
    
    
70. MILDNER S, Hotz I, Kubler F, Rausch L, et al
    Effects of activity-oriented physiotherapy with and without eye movement training on dynamic balance, functional mobility, and eye movements in patients with Parkinson's disease: An assessor-blinded randomised controlled pilot trial.
    PLoS One. 2024;19:e0304788.
    PubMed     Abstract available
    
    
    
71. HARRIS DM, O'Bryan SJ, Latella C
    Non-invasive brain stimulation as treatment for motor impairment in people with Parkinson's disease: Protocol for an umbrella review.
    PLoS One. 2024;19:e0304717.
    PubMed     Abstract available
    
    
    
72. AGLEY L, Hartley P, Lafortune L
    Exploring the experiences, priorities and preferences of people living with Parkinson's on exercise and physical activity promotion in the UK.
    PLoS One. 2024;19:e0304223.
    PubMed     Abstract available
    
    
    
73. CRIGHTON EJ, Ouedraogo AM, Sawada M, Mestre TA, et al
    Patterns and determinants of health care utilization among people with Parkinson's disease: A population-based analysis in Ontario, Canada.
    PLoS One. 2024;19:e0305062.
    PubMed     Abstract available
    
    
    
74. YALCIN M, Peralta AR, Bentes C, Silva C, et al
    Molecular characterization of the circadian clock in patients with Parkinson's disease-CLOCK4PD Study protocol.
    PLoS One. 2024;19:e0305712.
    PubMed     Abstract available
    
    
    
75. GORJI A, Fathi Jouzdani A
    Machine learning for predicting cognitive decline within five years in Parkinson's disease: Comparing cognitive assessment scales with DAT SPECT and clinical biomarkers.
    PLoS One. 2024;19:e0304355.
    PubMed     Abstract available
    
    
    
76. BOSCH-BARCELO P, Climent-Sanz C, Martinez-Navarro O, Masbernat-Almenara M, et al
    A treadmill training program in a gamified virtual reality environment combined with transcranial direct current stimulation in Parkinson's Disease: Study protocol for a randomized controlled trial.
    PLoS One. 2024;19:e0307304.
    PubMed     Abstract available
    
    
    
77. WANG K, Han C, Yang J, Xu W, et al
    Benfotiamine protects MPTP-induced Parkinson's disease mouse model via activating Nrf2 signaling pathway.
    PLoS One. 2024;19:e0307012.
    PubMed     Abstract available
    
    
    
78. STEINBACH S, Molina M, Grinberg LT, Aring L, et al
    Don't die like me: Which proteins are responsible for the selective neuronal vulnerability within the substantia nigra?
    PLoS One. 2024;19:e0296730.
    PubMed     Abstract available
    
    
    
79. FUNG KW, Baye F, Baik SH, McDonald CJ, et al
    Tamsulosin use in benign prostatic hyperplasia and risks of Parkinson's disease, Alzheimer's disease and mortality: An observational cohort study of elderly Medicare enrollees.
    PLoS One. 2024;19:e0309222.
    PubMed     Abstract available
    
    
    
80. USAMI N, Maegawa H, Hayashi M, Kudo C, et al
    Changes in the analgesic mechanism of oxytocin can contribute to hyperalgesia in Parkinson's disease model rats.
    PLoS One. 2024;19:e0300081.
    PubMed     Abstract available
    
    
    
81. THIES T, Barbe MT, Mucke D
    Prosody matters: Preserved prominence marking strategies in people with Parkinson's disease independent of motor status.
    PLoS One. 2024;19:e0308655.
    PubMed     Abstract available
    
    
    
82. PETERSEN I, Godec A, Ranjbarian F, Hofer A, et al
    A charged tail on anti-alpha-Synuclein antibodies does not enhance their affinity to alpha-Synuclein fibrils.
    PLoS One. 2024;19:e0308521.
    PubMed     Abstract available
    
    
    
83. MORAES IAP, Collett J, Silva TDD, Franssen M, et al
    Sensorimotor functioning changes in response to global exercise versus handwriting upper limb exercise training in Parkinson's disease, results from a phase II randomised controlled trial.
    PLoS One. 2024;19:e0309217.
    PubMed     Abstract available
    
    
    
84. RAMIREZ J, Saleh IG, Yanagawa ESK, Shimogawa M, et al
    Multivalency drives interactions of alpha-synuclein fibrils with tau.
    PLoS One. 2024;19:e0309416.
    PubMed     Abstract available
    
    
    
85. XU N, Xing S, Li J, Pang B, et al
    Water extract of ginseng alleviates parkinsonism in MPTP-induced Parkinson's disease mice.
    PLoS One. 2024;19:e0296424.
    PubMed     Abstract available
    
    
    
86. MINNELLA A, McCusker KP, Amagata A, Trias B, et al
    Targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of Parkinson's disease.
    PLoS One. 2024;19:e0309893.
    PubMed     Abstract available
    
    
    
87. LIU K, An J, Zhang J, Zhao J, et al
    Network pharmacology combined with experimental validation show that apigenin as the active ingredient of Campsis grandiflora flower against Parkinson's disease by inhibiting the PI3K/AKT/NF-kappaB pathway.
    PLoS One. 2024;19:e0311824.
    PubMed     Abstract available
    
    
    
88. HERATH HMMTB, Wijayawardhana KWSM, Wickramarachchi UI, Senanayake S, et al
    Impulse control disorders and other non-motor symptoms in Sri Lankan patients with Parkinson's disease.
    PLoS One. 2024;19:e0312342.
    PubMed     Abstract available
    
    
    
89. SAIBENE FL, Agliardi C, Salvatore A, Arcuri P, et al
    Investigating the effects of a daily multidisciplinary intensive outpatient rehabilitation program on innovative biomarkers in people with Parkinson's disease: Study protocol for a phase III randomized controlled clinical trial.
    PLoS One. 2024;19:e0309405.
    PubMed     Abstract available
    
    
    
90. NOMOTO M, Tsuboi Y, Kashihara K, Chiu SW, et al
    Prescription trends in Japanese advanced Parkinson's disease patients with non-motor symptoms: J-FIRST.
    PLoS One. 2024;19:e0309297.
    PubMed     Abstract available
    
    
    
91. PARK S, Lee J, Kim JY, Park JH, et al
    Clinical significance of MRI-measured olfactory bulb height as an imaging biomarker of idiopathic Parkinson's disease.
    PLoS One. 2024;19:e0312728.
    PubMed     Abstract available
    
    
    
92. MOHD AMIN NI, Mohd Nordin NA, Ismail A, Pillai SGK, et al
    A single-blind, randomised control trial on the effectiveness of a structured multi component training module for family caregiver of persons with Parkinson's disease: A study protocol.
    PLoS One. 2024;19:e0309648.
    PubMed     Abstract available
    
    
    
93. WANG Z, Xia H, Ding Y, Lu R, et al
    No association between genetically predicted vitamin D levels and Parkinson's disease.
    PLoS One. 2024;19:e0313631.
    PubMed     Abstract available
    
    
    
94. KHAN A, Ullah F, Alkreathy HM, Ahmed M, et al
    Phytochemical screening, antioxidant and anti-Parkinson activities of Berula erecta: A novel medicinal plant.
    PLoS One. 2024;19:e0305751.
    PubMed     Abstract available
    
    
    
95. REGAN EW, Burnitz O, Hightower J, Dobner L, et al
    Rock Steady Boxing: A qualitative evaluation of a community exercise program for people with Parkinson's disease.
    PLoS One. 2024;19:e0309522.
    PubMed     Abstract available
    
    
    
96. NAGY NS, Helal M, Alsawy ES, Ali MM, et al
    Paracentrotus lividus sea urchin gonadal extract mitigates neurotoxicity and inflammatory signaling in a rat model of Parkinson's disease.
    PLoS One. 2024;19:e0315858.
    PubMed     Abstract available
    
    
    
97. CARMICHAEL-LOWE A, Fleming B, Reddy K, Wiseman J, et al
    Enhanced detection of distinct honeycomb-structured neuronal SMARCC2 cytobodies in Parkinson's Disease via Cyclic Heat-Induced Epitope Retrieval (CHIER).
    PLoS One. 2024;19:e0315183.
    PubMed     Abstract available
    
    
    
98. 
    Retraction: GDNF-Transfected Macrophages Produce Potent Neuroprotective Effects in Parkinson's Disease Mouse Model.
    PLoS One. 2024;19:e0314546.
    PubMed    
    
    
    
99. HODGSON P, Jordan A, Sinani C, Charura D, et al
    Psycho-physical interactions in Parkinson's Disease: Protocol for a prospective observational cohort study.
    PLoS One. 2024;19:e0315345.
    PubMed     Abstract available
    
    
    
100. SHIM SR, Kim JY, Kwon KY, Shin J, et al
     Effects of rivastigmine on gait in patients with neurodegenerative disorders: A systematic review and meta-analysis.
     PLoS One. 2024;19:e0310900.
     PubMed     Abstract available
     
     
     
101. SAADULLAH M, Sehar A, Chauhdary Z, Siddique R, et al
     Anti-neuroinflammatory and neuroprotective potential of Cissus tuberosa ethanol extract in Parkinson's disease model through the modulation of neuroinflammatory markers.
     PLoS One. 2024;19:e0311140.
     PubMed     Abstract available
     
     
     
102. LI T, Guo J
     Identifying the NEAT1/miR-26b-5p/S100A2 axis as a regulator in Parkinson's disease based on the ferroptosis-related genes.
     PLoS One. 2024;19:e0316179.
     PubMed     Abstract available
     
     
     
103. PINTO C, Simon Myra R, Severo do Pinho A, Pereira F, et al
     Quality assessment and umbrella review of systematic reviews about dance for people with Parkinson's disease.
     PLoS One. 2024;19:e0311003.
     PubMed     Abstract available
     
     
     January 2023
104. CHUNG JW, Knight CA, Bower AE, Martello JP, et al
     Rate control deficits during pinch grip and ankle dorsiflexion in early-stage Parkinson's disease.
     PLoS One. 2023;18:e0282203.
     PubMed     Abstract available
     
     
     
105. CARVAJAL-OLIVEROS A, Dominguez-Baleon C, Sanchez-Diaz I, Zambrano-Tipan D, et al
     Parkinsonian phenotypes induced by Synphilin-1 expression are differentially contributed by serotonergic and dopaminergic circuits and suppressed by nicotine treatment.
     PLoS One. 2023;18:e0282348.
     PubMed     Abstract available
     
     
     
106. ALI DE, Bassam SM, Elatrebi S, Habiba ES, et al
     HR LC-MS/MS metabolomic profiling of Yucca aloifolia fruit and the potential neuroprotective effect on rotenone-induced Parkinson's disease in rats.
     PLoS One. 2023;18:e0282246.
     PubMed     Abstract available
     
     
     
107. TAN QY, Roberts HC, Fraser SDS, Amar K, et al
     What are the modifiable factors of treatment burden and capacity among people with Parkinson's disease and their caregivers: A qualitative study.
     PLoS One. 2023;18:e0283713.
     PubMed     Abstract available
     
     
     
108. VAN DER LIJN I, de Haan GA, van der Feen FE, Huizinga F, et al
     Prevalence and nature of self-reported visual complaints in people with Parkinson's disease-Outcome of the Screening Visual Complaints questionnaire.
     PLoS One. 2023;18:e0283122.
     PubMed     Abstract available
     
     
     
109. HWANG KS, Langley J, Tripathi R, Hu XP, et al
     In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson's disease using neuromelanin-sensitive MRI: Replication in two cohorts.
     PLoS One. 2023;18:e0282684.
     PubMed     Abstract available
     
     
     
110. CAMPI M, Peters GW, Toczydlowska D
     Ataxic speech disorders and Parkinson's disease diagnostics via stochastic embedding of empirical mode decomposition.
     PLoS One. 2023;18:e0284667.
     PubMed     Abstract available
     
     
     
111. ANWER DM, Gubinelli F, Kurt YA, Sarauskyte L, et al
     A comparison of machine learning approaches for the quantification of microglial cells in the brain of mice, rats and non-human primates.
     PLoS One. 2023;18:e0284480.
     PubMed     Abstract available
     
     
     
112. ALLWRIGHT M, Mundell H, Sutherland G, Austin P, et al
     Machine learning analysis of the UK Biobank reveals IGF-1 and inflammatory biomarkers predict Parkinson's disease risk.
     PLoS One. 2023;18:e0285416.
     PubMed     Abstract available
     
     
     
113. MACLAGAN LC, Marras C, Sewell IJ, Wu CF, et al
     Trends in health service use among persons with Parkinson's disease by rurality: A population-based repeated cross-sectional study.
     PLoS One. 2023;18:e0285585.
     PubMed     Abstract available
     
     
     
114. HIRANO M, Samukawa M, Isono C, Nagai Y, et al
     The effects of safinamide on dysphagia in Parkinson's disease.
     PLoS One. 2023;18:e0286066.
     PubMed     Abstract available
     
     
     
115. DAS J, Barry G, Walker R, Vitorio R, et al
     The integration of technology into a home-based visuo-cognitive training intervention for people with Parkinson's: Is the future digital?
     PLoS One. 2023;18:e0285100.
     PubMed     Abstract available
     
     
     
116. ESCHWEILER M, McCrum C, Giannouli E
     A registered report of a crossover study on the effects of face masks on walking adaptability in people with Parkinson's disease and multiple sclerosis.
     PLoS One. 2023;18:e0286402.
     PubMed     Abstract available
     
     
     
117. CHAND DA, Scadeng M, Dieriks BV
     Absolute quantification of neuromelanin in formalin-fixed human brains using absorbance spectrophotometry.
     PLoS One. 2023;18:e0288327.
     PubMed     Abstract available
     
     
     
118. MARTINDALE JM, Sarva H, Martino D, Gilbert DL, et al
     Study protocol: A cross-sectional survey of clinicians to identify barriers to clinical practice guideline implementation in the assessment and treatment of persistent tic disorders.
     PLoS One. 2023;18:e0288408.
     PubMed     Abstract available
     
     
     
119. PARAJULI M, Amara AW, Shaban M
     Deep-learning detection of mild cognitive impairment from sleep electroencephalography for patients with Parkinson's disease.
     PLoS One. 2023;18:e0286506.
     PubMed     Abstract available
     
     
     
120. SORRELL L, Leta V, Barnett A, Stevens K, et al
     Clinical features and outcomes of hospitalised patients with COVID-19 and Parkinsonian disorders: A multicentre UK-based study.
     PLoS One. 2023;18:e0285349.
     PubMed     Abstract available
     
     
     
121. ZAMORA-URSULO MA, Perez-Becerra J, Tellez LA, Saderi N, et al
     Reversal of pathological motor behavior in a model of Parkinson's disease by striatal dopamine uncaging.
     PLoS One. 2023;18:e0290317.
     PubMed     Abstract available
     
     
     
122. BRITO SAF, Scianni AA, Silveira BMF, Oliveira ERM, et al
     Effects of high-intensity respiratory muscle training on respiratory muscle strength in individuals with Parkinson's disease: Protocol of a randomized clinical trial.
     PLoS One. 2023;18:e0291051.
     PubMed     Abstract available
     
     
     
123. CROOKS S, Carter G, Wilson CB, Wynne L, et al
     Exploring public perceptions and awareness of Parkinson's disease: A scoping review.
     PLoS One. 2023;18:e0291357.
     PubMed     Abstract available
     
     
     
124. CHIU YS, Wu KJ, Yu SJ, Wu KL, et al
     Peptide immunization against the C-terminal of alpha-synuclein reduces locomotor activity in mice overexpressing alpha-synuclein.
     PLoS One. 2023;18:e0291927.
     PubMed     Abstract available
     
     
     
125. BATTISTA L, Casali M, Brusa L, Radicati FG, et al
     Clinical assessment of a new wearable tool for continuous and objective recording of motor fluctuations and ON/OFF states in patients with Parkinson's disease.
     PLoS One. 2023;18:e0287139.
     PubMed     Abstract available
     
     
     
126. VOLLSTEDT EJ, Madoev H, Aasly A, Ahmad-Annuar A, et al
     Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project.
     PLoS One. 2023;18:e0292180.
     PubMed     Abstract available
     
     
     
127. OKEMUO AJ, Gallagher D, Dairo YM
     Effects of rebound exercises on balance and mobility of people with neurological disorders: A systematic review.
     PLoS One. 2023;18:e0292312.
     PubMed     Abstract available
     
     
     
128. GUTOWSKI T, Antkiewicz R, Szlufik S
     Machine learning with optimization to create medicine intake schedules for Parkinson's disease patients.
     PLoS One. 2023;18:e0293123.
     PubMed     Abstract available
     
     
     
129. PADILHA C, Souza R, Grossl FS, Gauer APM, et al
     Physical exercise and its effects on people with Parkinson's disease: Umbrella review.
     PLoS One. 2023;18:e0293826.
     PubMed     Abstract available
     
     
     
130. THANPRASERTSUK S, Phowthongkum P, Hopetrungraung T, Poorirerngpoom C, et al
     Levodopa-induced dyskinesia in early-onset Parkinson's disease (EOPD) associates with glucocerebrosidase mutation: A next-generation sequencing study in EOPD patients in Thailand.
     PLoS One. 2023;18:e0293516.
     PubMed     Abstract available
     
     
     
131. LEE SH, Chung KC
     USP7 attenuates endoplasmic reticulum stress-induced apoptotic cell death through deubiquitination and stabilization of FBXO7.
     PLoS One. 2023;18:e0290371.
     PubMed     Abstract available
     
     
     
132. MCCANN E, Lee S, Coleman F, O'Sullivan JD, et al
     Pareidolias are a function of visuoperceptual impairment.
     PLoS One. 2023;18:e0293942.
     PubMed     Abstract available
     
     
     
133. O'MALLEY N, Coote S, Staunton FM, O'Connor E, et al
     A core outcome set for evaluating the effectiveness of mixed-diagnosis falls prevention interventions for people with Multiple Sclerosis, Parkinson's Disease and stroke.
     PLoS One. 2023;18:e0294193.
     PubMed     Abstract available
     
     
     
134. SENA IG, Costa AVD, Santos IKD, Araujo DP, et al
     Feasibility and effect of high-intensity training on the progression of motor symptoms in adult individuals with Parkinson's disease: A systematic review and meta-analysis.
     PLoS One. 2023;18:e0293357.
     PubMed     Abstract available
     
     
     
135. MAGANA JC, Deus CM, Baldellou L, Avellanet M, et al
     Investigating the impact of physical activity on mitochondrial function in Parkinson's disease (PARKEX): Study protocol for A randomized controlled clinical trial.
     PLoS One. 2023;18:e0293774.
     PubMed     Abstract available
     
     
     
136. MORADI VASTEGANI S, Khoshnam SE, Ghafouri S, Bakhtiari N, et al
     Anethole attenuates motor dysfunctions, striatal neuronal activity deficiency and blood brain barrier permeability by decreasing striatal alpha-synuclein and oxidative stress in rotenone-induced Parkinson's disease of male rats.
     PLoS One. 2023;18:e0294612.
     PubMed     Abstract available
     
     
     
137. XIN G, Niu J, Tian Q, Fu Y, et al
     Identification of potential immune-related hub genes in Parkinson's disease based on machine learning and development and validation of a diagnostic classification model.
     PLoS One. 2023;18:e0294984.
     PubMed     Abstract available
     
     
     
138. HONG JT, Jung HK, Lee KJ, Gong EJ, et al
     Potential risk of proton pump inhibitors for Parkinson's disease: A nationwide nested case-control study.
     PLoS One. 2023;18:e0295981.
     PubMed     Abstract available
     
     
     
139. CHEN L, Xin G, He Y, Tian Q, et al
     Study of molecular patterns associated with ferroptosis in Parkinson's disease and its immune signature.
     PLoS One. 2023;18:e0295699.
     PubMed     Abstract available
     
     
     
140. BORGHESI F, Mancuso V, Bruni F, Cremascoli R, et al
     Mental flexibility assessment: A research protocol for patients with Parkinson's Disease and Anorexia Nervosa.
     PLoS One. 2023;18:e0293921.
     PubMed     Abstract available
     
     
     
141. MERCER HM, Nair AM, Ridgel A, Piontkivska H, et al
     Alterations in RNA editing in skeletal muscle following exercise training in individuals with Parkinson's disease.
     PLoS One. 2023;18:e0287078.
     PubMed     Abstract available
     
     
     
142. HATTORI N, Kabata D, Asada S, Kanda T, et al
     Real-world evidence on levodopa dose escalation in patients with Parkinson's disease treated with istradefylline.
     PLoS One. 2023;18:e0269969.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.